Dolby Laboratories (DLB) Tops Q2 EPS by 4c, provides guidance

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $1.37, $0.04 better than the analyst estimate of $1.33. Revenue for the quarter came in at $396 million versus the consensus estimate of $385.8 million.

GUIDANCE:

Dolby Laboratories sees Q3 2026 EPS of $0.56-$0.71, versus the consensus of $0.98. Dolby Laboratories sees Q3 2026 revenue of $295-325 million, versus the consensus of $343.5 million.

Dolby Laboratories sees FY2026 EPS of $4.30-$4.45, versus the consensus of $4.34. Dolby Laboratories sees FY2026 revenue of $1.4-1.45 billion, versus the consensus of $1.417 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Select Medical stockholders approve buyout by insider-led consortium
• Matinas BioPharma gets NYSE American compliance notice